These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 25698402
1. A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix. Dineen SP, Royal RE, Hughes MS, Sagebiel T, Bhosale P, Overman M, Matamoros A, Mansfield PF, Fournier KF. Ann Surg Oncol; 2015 Oct; 22(11):3640-6. PubMed ID: 25698402 [Abstract] [Full Text] [Related]
2. External Validation of the Simplified Preoperative Assessment for Low-Grade Mucinous Adenocarcinoma of the Appendix. Milovanov V, Sardi A, Aydin N, Nieroda C, Sittig M, Gushchin V. Ann Surg Oncol; 2017 Jul; 24(7):1783-1786. PubMed ID: 28315061 [Abstract] [Full Text] [Related]
3. Preoperative Radiographic Assessment Predicts Incomplete Cytoreduction in Patients with Low Grade Mucinous Adenocarcinoma of the Appendix. Sabesan A, Felder S, Feuerlein S, Lam C, McGettigan M, Powers BD, Dessureault S, Dineen SP. Ann Surg Oncol; 2020 Jan; 27(1):165-170. PubMed ID: 31388776 [Abstract] [Full Text] [Related]
4. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours. Lord AC, Shihab O, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Eur J Surg Oncol; 2015 Mar; 41(3):396-9. PubMed ID: 25216980 [Abstract] [Full Text] [Related]
7. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. El Halabi H, Gushchin V, Francis J, Athas N, Macdonald R, Nieroda C, Studeman K, Sardi A. Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929 [Abstract] [Full Text] [Related]
8. Management of an inguinal hernia in patients with pseudomyxoma peritonei. Sugarbaker PH. Eur J Surg Oncol; 2017 Jun; 43(6):1083-1087. PubMed ID: 28131668 [Abstract] [Full Text] [Related]
9. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM. Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504 [Abstract] [Full Text] [Related]
10. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection. Grotz TE, Overman MJ, Eng C, Raghav KP, Royal RE, Mansfield PF, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF. Ann Surg Oncol; 2017 Sep; 24(9):2646-2654. PubMed ID: 28695394 [Abstract] [Full Text] [Related]
11. Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Chua TC, Al-Zahrani A, Saxena A, Glenn D, Liauw W, Zhao J, Morris DL. Ann Surg Oncol; 2011 Jun; 18(6):1582-9. PubMed ID: 21207170 [Abstract] [Full Text] [Related]
12. Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix. Sparks DS, Morris B, Xu W, Fulton J, Atkinson V, Meade B, Lutton N. Int Surg; 2015 Jan; 100(1):21-8. PubMed ID: 25594636 [Abstract] [Full Text] [Related]
13. Extensive surgical history prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with poor survival outcomes in patients with peritoneal mucinous carcinomatosis of appendiceal origin. Milovanov V, Sardi A, Aydin N, Nieroda C, Sittig M, Nunez M, Gushchin V. Eur J Surg Oncol; 2015 Jul; 41(7):881-5. PubMed ID: 25899982 [Abstract] [Full Text] [Related]
14. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Jimenez W, Sardi A, Nieroda C, Sittig M, Milovanov V, Nunez M, Aydin N, Gushchin V. Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239 [Abstract] [Full Text] [Related]
16. Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis. Marcotte E, Dubé P, Drolet P, Mitchell A, Frenette S, Leblanc G, Leclerc YE, Sideris L. World J Surg Oncol; 2014 Nov 07; 12():332. PubMed ID: 25380618 [Abstract] [Full Text] [Related]
17. Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms. Polanco PM, Ding Y, Knox JM, Ramalingam L, Jones H, Hogg ME, Zureikat AH, Holtzman MP, Pingpank J, Ahrendt S, Zeh HJ, Bartlett DL, Choudry HA. Ann Surg Oncol; 2016 Feb 07; 23(2):382-90. PubMed ID: 26429720 [Abstract] [Full Text] [Related]
19. Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study. Baratti D, Kusamura S, Milione M, Pietrantonio F, Caporale M, Guaglio M, Deraco M. Ann Surg Oncol; 2016 Dec 07; 23(13):4222-4230. PubMed ID: 27352203 [Abstract] [Full Text] [Related]
20. Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA). Milovanov V, Sardi A, Ledakis P, Aydin N, Nieroda C, Sittig M, Nunez M, Gushchin V. Eur J Surg Oncol; 2015 May 07; 41(5):707-12. PubMed ID: 25633641 [Abstract] [Full Text] [Related] Page: [Next] [New Search]